Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
Acta Neurologica Scandinavica
|
May 1, 1997
Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone
D Franciotta, G Piccolo, E Zardini, et al.
Acta Neurologica Scandinavica
|
September 1, 1996
Antigen-specific oligoclonal IgG in AIDS-related cytomegalovirus and toxoplasma encephalitis
D Franciotta, E Zardini, G Bono, et al.
European Cytokine Network
|
September 8, 1999
Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone
D Franciotta, R Bergamaschi, G Martino, et al.
Functional Neurology
|
May 9, 2002
The relevance of cytokines within the immuno-inflammatory response: are they reliably measurable in biological fluids?
D Franciotta, E Zardini, R Bergamaschi, et al.
Multiple Sclerosis and Related Disorders
|
November 24, 2018
Tocilizumab in MOG-antibody spectrum disorder: a case report
G Novi, M Gastaldi, D Franciotta, et al.
Acta Neurologica Scandinavica
|
September 9, 2005
Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases
D Franciotta, E Zardini, R Bergamaschi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 1, 1996
Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment
G Piccolo, D Franciotta, M Versino, et al.
Journal of Neurology
|
August 13, 2005
Long term disability and social status change after Guillain-Barré syndrome
A Bersano, M Carpo, S Allaria, et al.
Clinical Neurology and Neurosurgery
|
July 23, 2019
"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?"
C Lapucci, L Benedetti, C Tavarelli, et al.
Journal of Neuroimmunology
|
April 3, 2001
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
D Franciotta, G Martino, E Zardini, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
Acta Neurologica Scandinavica
|
May 1, 1997
Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone
D Franciotta, G Piccolo, E Zardini, et al.
Acta Neurologica Scandinavica
|
September 1, 1996
Antigen-specific oligoclonal IgG in AIDS-related cytomegalovirus and toxoplasma encephalitis
D Franciotta, E Zardini, G Bono, et al.
European Cytokine Network
|
September 8, 1999
Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone
D Franciotta, R Bergamaschi, G Martino, et al.
Functional Neurology
|
May 9, 2002
The relevance of cytokines within the immuno-inflammatory response: are they reliably measurable in biological fluids?
D Franciotta, E Zardini, R Bergamaschi, et al.
Multiple Sclerosis and Related Disorders
|
November 24, 2018
Tocilizumab in MOG-antibody spectrum disorder: a case report
G Novi, M Gastaldi, D Franciotta, et al.
Acta Neurologica Scandinavica
|
September 9, 2005
Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases
D Franciotta, E Zardini, R Bergamaschi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 1, 1996
Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment
G Piccolo, D Franciotta, M Versino, et al.
Journal of Neurology
|
August 13, 2005
Long term disability and social status change after Guillain-Barré syndrome
A Bersano, M Carpo, S Allaria, et al.
Clinical Neurology and Neurosurgery
|
July 23, 2019
"Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?"
C Lapucci, L Benedetti, C Tavarelli, et al.
Journal of Neuroimmunology
|
April 3, 2001
Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies
D Franciotta, G Martino, E Zardini, et al.
Page
of 7